98%
921
2 minutes
20
The assessment of boron microdistribution is essential to evaluate the suitability of boron neutron capture therapy (BNCT) in different biological models. In our laboratory, we have reported a methodology to produce cell imprints on polycarbonate through UV-C sensitization. The aim of this work is to extend the technique to tissue samples in order to enhance spatial resolution. As tissue structure largely differs from cultured cells, several aspects must be considered. We studied the influence of the parameters involved in the imprint and nuclear track formation, such as neutron fluence, different NTDs, etching and UV-C exposure times, tissue absorbance, thickness, and staining, among others. Samples from different biological models of interest for BNCT were used, exhibiting homogeneous and heterogeneous histology and boron microdistribution. The optimal conditions will depend on the animal model under study and the resolution requirements. Both the imprint sharpness and the fading effect depend on tissue thickness. While 6 h of UV-C was necessary to yield an imprint in CR-39, only 5 min was enough to observe clear imprints on Lexan. The information related to microdistribution of boron obtained with neutron autoradiography is of great relevance when assessing new boron compounds and administration protocols and also contributes to the study of the radiobiology of BNCT.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381447 | PMC |
http://dx.doi.org/10.3390/life13071578 | DOI Listing |
Radiat Environ Biophys
August 2025
Dpto. Radiobiología, Centro Atómico Constituyentes, Comisión Nacional de Energía Atómica (CNEA), Av. General Paz 1499, Provincia de Bs.As, San Martín, B1650KNA, Argentina.
The high mortality and morbidity of Head and Neck cancer patients and the toxicity associated to oncological treatments suggest the need for more selective and non-toxic therapies. BNCT (Boron Neutron Capture Therapy) is based on the capture reaction between boron-10, selectively targeted to tumor tissue, and a thermal neutron. In this study, an oral cancer and precancer model was used to study the therapeutic effect and radiotoxicity of BNCT mediated by BPA (boronphenylalanine) [BPA-BNCT] at short and medium-term follow-up.
View Article and Find Full Text PDFAppl Radiat Isot
November 2025
Comisión Nacional de Energía Atómica (CNEA), Centros Atómicos Constituyentes y Ezeiza, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2270, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address:
The biodistribution of boronophenylalanine (BPA), a widely used compound for Boron Neutron Capture Therapy (BNCT), is well characterized. In contrast, data on boric acid (BA) biodistribution remain limited. Given previously observed high boron levels in calcified tissues following BA administration, we conducted a comparative study to evaluate its accumulation and retention in bone.
View Article and Find Full Text PDFInt J Radiat Biol
May 2025
Department of Nuclear Science and Technology, Nanjing University of Aeronautics and Astronautics, Nanjing, PR China.
Purpose: The micro-distribution of boron compounds within cells influences the effectiveness of boron neutron capture therapy (BNCT) in killing tumor cells. Boron neutron capture therapy-sensitive organelles within the range of α particles and Li recoil nuclei can enhance killing effects on tumor cells. However, comprehensive studies on the sensitive organelles to BNCT are currently lacking.
View Article and Find Full Text PDFAppl Radiat Isot
June 2025
CNEA, Av. Gral Paz 1499, B1650KNA, San Martín, Prov. Buenos Aires, Argentina; Escuela de Ciencia y Tecnología-UNSAM, Martín de Irigoyen 3100, 1650, San Martín, Prov. Buenos Aires, Argentina; CONICET Av. Rivadavia 1917, C1033AAJ, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: an
The interdisciplinary character of the BNCT endeavour is stressed ranging from nuclear physics to most of the natural and exact sciences. Radiobiology studies, carried out with accelerated proton, alpha and Li beams, are used to isolate the relative biological effectiveness of "pure" high LET radiation. Based on the survival curve results, we discuss the question of the use of fixed RBE factors to convert physical doses into equivalent or isoeffective gamma doses.
View Article and Find Full Text PDFMaterials (Basel)
January 2025
Department of Physics, University of Pavia, 27100 Pavia, Italy.
Boron Neutron-Capture Therapy (BNCT) is a form of radiation therapy that relies on the highly localized and enhanced biological effects of the B neutron capture (BNC) reaction products to selectively kill cancer cells. The efficacy of BNCT is, therefore, strongly dependent on the B spatial microdistribution at a subcellular level. Fluorescent Nuclear Track Detectors (FNTDs) could be a promising technology for measuring B microdistribution.
View Article and Find Full Text PDF